Zimmer Biomet Holdings (ZBH) Shares are Down -0.75%

Zimmer Biomet Holdings (ZBH) has risen sharply, recording gains of 6.68% in the past 4 weeks. However, the stock has corrected -0.75% in the past 1 week, providing a good buying opportunity on dips. Zimmer Biomet Holdings (ZBH) : During the past 4 weeks, traders have been relatively bearish on Zimmer Biomet Holdings (ZBH), hence the stock is down -0.07% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -1.36% relative to the S&P 500.

Zimmer Biomet Holdings (NYSE:ZBH): The stock opened at $124.79 on Friday but the bulls could not build on the opening and the stock topped out at $124.92 for the day. The stock traded down to $122.68 during the day, due to lack of any buying support eventually closed down at $124.48 with a loss of -0.65% for the day. The stock had closed at $125.29 on the previous day. The total traded volume was 1,532,798 shares.


The stock has recorded a 20-day Moving Average of 1.7% and the 50-Day Moving Average is 3.34%. Zimmer Biomet Holdings, Inc. is up 8.69% in the last 3-month period. Year-to-Date the stock performance stands at 21.86%.

Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc. is a musculoskeletal healthcare company. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company manages its operations through three geographic segments: the Americas, comprising principally of the United States and includes other North, Central and South American markets; Europe, comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific, comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers, and directly to dental practices and dental laboratories.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *